DOI: 10.1055/s-00000031

Klinische Monatsblätter für Augenheilkunde

References

Lushchyk T, Amarakoon S, Martinez-Ciriano JP. et al.
Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks.

Acta Ophthalmol 2013;
91: e456-e461
doi:10.1111/aos.12119

Download Bibliographical Data

Search in: